Biomed Central Ltd

SHERPA: Unknown

People

  1. Chaft
    Chaft
  2. Schoenfeld
    Schoenfeld
  3. Brown
    Brown
  4. Chen
    Chen
  5. Gomez
    Gomez
  6. Kris
    Kris
  7. Ladanyi
    Ladanyi
  8. Preeshagul
    Preeshagul
  9. Richards
    Richards
  10. Riely
    Riely

Groups

  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. Thoracic Oncology (6)
  4. GME, Medicine (2)
  5. Graduate Medical Education (2)
  6. Hematologic Malignancies, Division of (2)
  7. Hematology-Oncology Fellows (2)
  8. Population Sciences Research Program (2)
  9. Sloan Kettering Institute Postdocs (2)
  10. Weinberg Fellows (2)
Search Within
  1. "Jamie Chaft"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. Thoracic Oncology (6)
  4. GME, Medicine (2)
  5. Graduate Medical Education (2)
  6. Hematologic Malignancies, Division of (2)

More Groups

People
  1. Jamie Chaft (6)
  2. Adam Schoenfeld (2)
  3. Arielle Elkrief (2)
  4. Matthew Hellmann (2)
  5. Adam Price (1)
  6. Allison Richards (1)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2018 (1)
  4. 2015 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer
    Journal Article

    Alessi, J. V.; Price, A.; Richards, A. L.; Ricciuti, B.; Wang, X.; Elkrief, A.; Pecci, F.; Di Federico, A.; Gandhi, M. M.; Lebow, E. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Cd8+Foxp3+cells represent early, effector T-cells and predict outcomes in patients with resectable non-small cell lung carcinoma (NSCLC) receiving neoadjuvant anti-PD-1-based therapy
    Meeting Abstract

    Cohen, E.; Wang, D.; Engle, E.; Green, B.; Caushi, J.; Zhang, J.; Sunshine, J.; Uttam, S.; Fotheringham, M.; Fiorante, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy
    Journal Article

    Hwang, M.; Canzoniero, J. V.; Rosner, S.; Zhang, G.; White, J. R.; Belcaid, Z.; Cherry, C.; Balan, A.; Pereira, G.; Curry, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Peripheral T cell dynamics in resectable NSCLC patients treated with neoadjuvant PD-1 blockade
    Meeting Abstract

    Zhang, J.; Ji, Z.; El Asmar, M.; Caushi, J.; Anagnostou, V.; Chan, H. Y.; Suri, P.; Guo, H.; Marrone, K.; Naidoo, J.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Tumor response from durvalumab (MEDI4736) + tremelimumab treatment in patients with advanced non-small cell lung cancer (NSCLC) is observed regardless of PD-L1 status
    Meeting Abstract

    Rizvi, N.; Chaft, J.; Balmanoukian, A.; Goldberg, S. B.; Sanborn, R. E.; Steele, K. E.; Rebelatto, M. C.; Gu, Y.; Karakunnel, J. J.; Antonia, S.
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save